189 related articles for article (PubMed ID: 26789012)
1. Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.
Elbarbary NS
Diabetes Metab Res Rev; 2016 Sep; 32(6):623-33. PubMed ID: 26789012
[TBL] [Abstract][Full Text] [Related]
2. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.
Agrawal P; Welsh JB; Kannard B; Askari S; Yang Q; Kaufman FR
J Diabetes Sci Technol; 2011 Sep; 5(5):1137-41. PubMed ID: 22027306
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.
Danne T; Kordonouri O; Holder M; Haberland H; Golembowski S; Remus K; Bläsig S; Wadien T; Zierow S; Hartmann R; Thomas A
Diabetes Technol Ther; 2011 Nov; 13(11):1129-34. PubMed ID: 21827318
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia.
Morros-González E; Gómez AM; Henao Carrillo DC; Ursida V; Serrano S; Rondón Sepúlveda MA; Muñoz Velandia OM
Diabetes Metab Syndr; 2021; 15(3):649-653. PubMed ID: 33813236
[TBL] [Abstract][Full Text] [Related]
5. Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up.
Gómez AM; Henao DC; Taboada LB; Leguizamón G; Rondón MA; Muñoz OM; García-Jaramillo MA; León Vargas FM
Diabetes Metab Syndr; 2019; 13(4):2625-2631. PubMed ID: 31405686
[TBL] [Abstract][Full Text] [Related]
6. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
[TBL] [Abstract][Full Text] [Related]
7. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
[TBL] [Abstract][Full Text] [Related]
8. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
[TBL] [Abstract][Full Text] [Related]
9. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy.
Ly TT; Nicholas JA; Retterath A; Davis EA; Jones TW
Diabetes Care; 2012 Jul; 35(7):1462-5. PubMed ID: 22584133
[TBL] [Abstract][Full Text] [Related]
10. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.
Gómez AM; Henao DC; Imitola A; Muñoz OM; Sepúlveda MAR; Kattah L; Guerrero JS; Morros E; Llano JP; Jaramillo MG; León-Vargas F
Endocrinol Diabetes Nutr (Engl Ed); 2018 Oct; 65(8):451-457. PubMed ID: 29914817
[TBL] [Abstract][Full Text] [Related]
12. The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.
Brazg RL; Bailey TS; Garg S; Buckingham BA; Slover RH; Klonoff DC; Nguyen X; Shin J; Welsh JB; Lee SW
J Diabetes Sci Technol; 2011 Nov; 5(6):1466-71. PubMed ID: 22226267
[TBL] [Abstract][Full Text] [Related]
13. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
[TBL] [Abstract][Full Text] [Related]
14. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N
Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function.
Abraham MB; Nicholas JA; Ly TT; Roby HC; Paramalingam N; Fairchild J; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
BMJ Open; 2016 Apr; 6(4):e011589. PubMed ID: 27084290
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
17. Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK.
Choudhary P; de Portu S; Arrieta A; Castañeda J; Campbell FM
Diabet Med; 2019 Sep; 36(9):1100-1108. PubMed ID: 31134668
[TBL] [Abstract][Full Text] [Related]
18. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial.
Elbarbary NS; Ismail EAR
Diabetes Res Clin Pract; 2022 Sep; 191():110045. PubMed ID: 35987309
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
[TBL] [Abstract][Full Text] [Related]
20. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.
Choudhary P; Shin J; Wang Y; Evans ML; Hammond PJ; Kerr D; Shaw JA; Pickup JC; Amiel SA
Diabetes Care; 2011 Sep; 34(9):2023-5. PubMed ID: 21868778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]